Work

Who is in charge of assessing therapeutic drug monitoring? The case of imatinib

Year: 2010

Type: article

Source: The Lancet Oncology

DOI: 10.1016/s1470-2045(10)70258-8

Authors: Thierry Buclin, Nicolas Widmer, Jerome Biollaz, Laurent A Decosterd

Institutions: Centre Hospitalier Universitaire Vaudois, University of Lausanne

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2019197289

FWCI: 1.765

Cites: 11

Cited by: 26

Related to: 10